Search
for
Sort by
Research 481–510 of 1000+
- Flares of systemic lupus erythematosus during pregnancy and the puerperium: prevention, diagnosis and management
- Pharmacological Activity and Clinical Use of PDRN
- Dupilumab in Inflammatory Skin Diseases: A Systematic Review
- Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- Combined Sabal and Urtica extract vs finasteride in BPH (Alken stage I–II)
- Therapeutic, Prophylactic, and Functional Use of Probiotics: A Current Perspective
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- New 5?-reductase inhibitors: In vitro and in vivo effects
- Current Status of Fractional Laser Resurfacing
- An observational retrospective evaluation of 79 young men with long-term adverse effects after use of finasteride against androgenetic alopecia
- Baricitinib: From Rheumatoid Arthritis to COVID‐19
- Management of tinea capitis in childhood
- Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19
- Therapeutic Potential of Brassinosteroids in Biomedical and Clinical Research
- PPAR‐γ signalling as a key mediator of human hair follicle physiology and pathology
- Role of liposomal anthracyclines in the treatment of multiple myeloma
- Doxycycline, an antibiotic or an anti-inflammatory agent? The Most Common uses in dermatology
- Getting under the skin: what is the potential of the transfollicular route in drug delivery?
- Long-term treatment with finasteride 1 mg decreases the likelihood of developing further visible hair loss in men with androgenetic alopecia (male pattern hair loss).
- The anti-inflammatory and analgesic activities of 2Br-Crebanine and Stephanine from Stephania yunnanenses H. S.Lo
- 5α‐Reductase Inhibitors
- Early COVID-19 Therapy with Azithromycin Plus Nitazoxanide, Ivermectin or Hydroxychloroquine in Outpatient Settings Significantly Reduced Symptoms Compared to Known Outcomes in Untreated Patients.
- An ethnopharmacological and historical analysis of “Dictamnus”, a European traditional herbal medicine
- Oral minoxidil improves background hair thickness in lichen planopilaris
- A review on the chemical constituents and pharmacological efficacies of Lindera aggregata (Sims) Kosterm
- New developing multiple sclerosis in a patient using tofacitinib due to alopesia areata
- Early COVID-19 Therapy with Azithromycin Plus Nitazoxanide, Ivermectin or Hydroxychloroquine in Outpatient Settings Significantly Reduced Symptoms Compared to Known Outcomes in Untreated Patients
- Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One
- The rise of transcutaneous drug delivery for the management of alopecia: a review of existing literature and an eye towards the future
- Hair Growth Promotion Effect and Anti-bacterial Activity against Pityrosporum ovale of Peppermint Oil